
Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and ...
Introduction Senile osteoporosis is characterized by deterioration of the bone microstructure and reduced bone strength, resulting in a high fracture risk.1 With the dramatic increase in the global population of older adults, this disease has emerged as a …